Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1

Status

Recruiting 24Active not recruiting 17Completed 8Unknown 5Withdrawn 4Terminated 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 5

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Endocrine 5NET 3CNS 1

Conditions

Neuroendocrine Tumors 3Carcinoma, Neuroendocrine 2Serotonin Syndrome 1Paraganglioma 1Carcinoid Tumor 1Carcinoid Heart Disease 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Interventional × lutetium Lu 177 dotatate × Clear all
NCT02236910 2024-10-15

Lu-DOTA-TATE

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Unknown
66 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT05513469 2023-04-07

Radio-Marker

Erasmus Medical Center

Phase NA Unknown
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04525638 2022-08-02

A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours

Fundación de investigación HM

Phase 2 Unknown
30 enrolled
EndocrineNET

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04039516 2020-08-04

CHARRT

King's College Hospital NHS Trust

Phase 2 Unknown
20 enrolled
Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Serotonin Syndrome

NCT04029428 2020-04-01

POLNETS_PRRT

University of Warmia and Mazury

Phase 2 Unknown
150 enrolled
CNSEndocrineNET

Paraganglioma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡